Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-017097
Filing Date
2021-03-31
Accepted
2021-03-31 16:22:47
Documents
83
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bioc-10k_20201231.htm 10-K 3039903
2 EX-23.1 bioc-ex231_6.htm EX-23.1 2959
3 EX-31.1 bioc-ex311_11.htm EX-31.1 19222
4 EX-31.2 bioc-ex312_8.htm EX-31.2 19268
5 EX-32.1 bioc-ex321_7.htm EX-32.1 5284
6 EX-32.2 bioc-ex322_10.htm EX-32.2 5910
  Complete submission text file 0001564590-21-017097.txt   11967656

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bioc-20201231.xml EX-101.INS 2793020
8 XBRL TAXONOMY EXTENSION SCHEMA bioc-20201231.xsd EX-101.SCH 91811
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bioc-20201231_cal.xml EX-101.CAL 75943
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bioc-20201231_def.xml EX-101.DEF 289351
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20201231_lab.xml EX-101.LAB 660227
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20201231_pre.xml EX-101.PRE 504943
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

EIN.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36284 | Film No.: 21793660
SIC: 8071 Services-Medical Laboratories